TNF-α and IL-1β drive the inflammatory cascade, activating innate immunity and subsequent inflammatory responses (Koga et al., 2008) and repressing the TNF-α and IL-1β expressions positively influence AD (Chen et al., 2020). This evidence concerns the gene IL1B and Alzheimer disease.